Try
LivaNova PLC
LIVNUnited States
89 filed reports · 726 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
89 reports · Sep 2015 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 268 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 44 | 258 | Mar 2016 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 33 | 6,946 | Sep 2015 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 6,781 | Dec 2016 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 1 | Dec 2019 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 166 | Oct 2015 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 5, 2026 | 6 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 402 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 6, 2026 | 6 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 251 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 25, 2026 | 6 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 25, 2026 | 1,089 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 5, 2025 | 6 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 279 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 193 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 6, 2025 | 6 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 183 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 7, 2025 | 6 | Open |
Financial data
726 concepts · 14,152 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial681 concepts · 11,637 facts · Jul 2013 to Jul 2026
- Net income loss65 · Jul 2013 to Jun 2026
- Common stock par or stated value per share63 · Apr 2015 to Jun 2026
- Gross profit (US GAAP)63 · Jul 2013 to Jun 2026
- Revenue63 · Apr 2014 to Jun 2026
- Cash and cash equivalents at carrying value61 · Apr 2014 to Jun 2026
- Stockholders equity (US GAAP)61 · Apr 2014 to Jun 2026
- Comprehensive income net of tax60 · Apr 2014 to Jun 2026
- Earnings per share diluted60 · Jul 2013 to Jun 2026
- Income tax expense benefit60 · Apr 2014 to Jun 2026
- Operating income loss60 · Apr 2014 to Jun 2026
- Other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent60 · Apr 2014 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent60 · Apr 2014 to Jun 2026
- Research and development expense60 · Apr 2014 to Jun 2026
- Selling general and administrative expense60 · Apr 2014 to Jun 2026
- Cost of goods and services sold (US GAAP)59 · Apr 2014 to Jun 2026
- Depreciation58 · Apr 2014 to Jun 2026
- Provisions for agents, returns and other58 · Apr 2015 to Jun 2026
- Accounts payable current57 · Apr 2015 to Jun 2026
- Accounts receivable net current57 · Apr 2015 to Jun 2026
- Assets57 · Apr 2015 to Jun 2026
- Assets current57 · Apr 2015 to Jun 2026
- Common stock shares issued57 · Apr 2015 to Jun 2026
- Common stock shares outstanding57 · Apr 2015 to Jun 2026
- Common stock value57 · Apr 2015 to Jun 2026
Segment25 concepts · 1,661 facts · Apr 2014 to Jun 2026
- Revenue719 · Apr 2014 to Jun 2026
- Revenue (excluding assessed tax)143 · Mar 2018 to Jun 2026
- Goodwill122 · Dec 2015 to Jun 2026
- Restructuring charges110 · Mar 2016 to Dec 2025
- Goodwill translation and purchase accounting adjustments67 · Mar 2016 to Jun 2026
- Total Assets62 · Dec 2015 to Jun 2026
- Segment expenditure addition to long lived assets41 · Dec 2021 to Jun 2026
- Total Reportable Segments’ Income from Operations41 · Apr 2014 to Sep 2018
- Property plant and equipment additions39 · Apr 2014 to Sep 2017
- Goodwill acquired during period33 · Sep 2017 to Dec 2022
- Loss contingency accrual provision33 · Dec 2019 to Mar 2026
- Goodwill foreign currency translation gain loss31 · Dec 2016 to Dec 2025
- Depreciation depletion and amortization30 · Apr 2014 to Dec 2016
- Operating income loss29 · Dec 2021 to Jun 2026
- Cost of goods and services sold (US GAAP)28 · Dec 2022 to Jun 2026
- Research and development expense28 · Dec 2022 to Jun 2026
- Selling general and administrative expense28 · Dec 2022 to Jun 2026
- Operating Segments22 · Dec 2022 to Jun 2025
- Goodwill impairment loss20 · Mar 2016 to Dec 2022
- Goodwill purchase accounting adjustments18 · Dec 2016 to Dec 2022
- Goodwill other changes6 · Mar 2016 to Jun 2016
- Cardiovascular4 · Dec 2018 to Dec 2020
- Loss contingency loss in period4 · Jun 2025 to Jun 2026
- Fair value inputs discount rate2 · Dec 2016
Geography5 concepts · 420 facts · Apr 2014 to Jun 2026
- Revenue213 · Apr 2014 to Jun 2026
- Property, Plant & Equipment, Net180 · Apr 2015 to Jun 2026
- Saluggia, Italy19 · Mar 2020 to Jun 2025
- Loss contingency accrual provision5 · Dec 2020 to Dec 2022
- ITALY3 · Jul 2015 to Sep 2016
Guidance12 concepts · 258 facts · Feb 2016 to Aug 2026
- Revenue Growth Guidance82 · Feb 2016 to Aug 2026
- EPS (Diluted) Guidance80 · Feb 2016 to Aug 2026
- Free Cash Flow Guidance40 · Oct 2020 to Aug 2026
- Effective Tax Rate Guidance10 · Feb 2016 to Oct 2018
- Capital Expenditures Guidance8 · Mar 2017 to Feb 2020
- EPS (Diluted) Guidance (Adjusted (non-GAAP))6 · May 2024 to Oct 2024
- Free Cash Flow Guidance (Adjusted (non-GAAP))6 · May 2024 to Oct 2024
- Gross Margin Guidance6 · Feb 2016 to Aug 2016
- Operating Income Guidance6 · Feb 2016 to Aug 2016
- Revenue Growth Guidance (Constant currency)6 · May 2024 to Oct 2024
- Revenue Growth Guidance (excluding the impact of the ACS segment wind down; Constant currency)6 · May 2024 to Oct 2024
- Revenue Guidance2 · Apr 2019
Product3 concepts · 176 facts · Dec 2017 to Sep 2021
- Revenue174 · Dec 2017 to Sep 2021
- Goodwill impairment loss1 · Dec 2020
- Impairment of long lived assets to be disposed of1 · Dec 2020
Segments
2,257 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments14 members · 1,661 facts
- Neuromodulation467 · Apr 2014 to Jun 2026
- Cardiac Surgery313 · Apr 2014 to Sep 2019
- Cardiopulmonary258 · Dec 2019 to Jun 2026
- Cardiopulmonary segment127 · Dec 2018 to Jun 2026
- Cardiovascular122 · Dec 2017 to Sep 2021
- Advanced Circulatory Support99 · Dec 2019 to Dec 2023
- Neuromodulation segment87 · Dec 2015 to Jun 2026
- Cardiac Rhythm Management69 · Apr 2014 to Sep 2017
- Advanced circulatory support segment55 · Dec 2018 to Dec 2023
- Cardiac surgery29 · Dec 2015 to Sep 2019
- Cardiac rhythm management15 · Dec 2015 to Sep 2017
- Cardiovascular segment13 · Dec 2018 to Oct 2021
- All Other Segments6 · Dec 2022 to Dec 2024
- Other1 · Jun 2017
Statement geographicalsrt:StatementGeographicalAxis9 members · 213 facts
- Europe44 · Dec 2016 to Jun 2026
- US44 · Dec 2016 to Jun 2026
- Locations Excluding The United States And Europe38 · Dec 2018 to Jun 2026
- Locations excluding the united states and europe34 · Dec 2019 to Jun 2026
- Saluggia Italy24 · Mar 2020 to Jun 2025
- GB12 · Dec 2016 to Dec 2025
- Rest Of World12 · Dec 2016 to Dec 2019
- It3 · Dec 2023 to Dec 2025
- Rest of world2 · Dec 2018 to Dec 2019
Statement geographicalus-gaap:StatementGeographicalAxis13 members · 207 facts
- Us56 · Apr 2015 to Jun 2026
- Europe54 · Dec 2015 to Jun 2026
- US17 · Apr 2014 to Dec 2017
- Non U.S.and Europe15 · Apr 2014 to Dec 2017
- Europe13 · Apr 2014 to Dec 2017
- Non u.s.and europe12 · Dec 2015 to Dec 2018
- GB11 · Mar 2016 to Mar 2018
- Gb9 · Dec 2015 to Jun 2017
- Rest of world8 · Dec 2017 to Sep 2019
- FR5 · Jun 2016 to Sep 2017
- IT3 · Jul 2015 to Sep 2016
- International2 · Oct 2014 to Oct 2015
- International2 · Apr 2015 to Oct 2015
Product or service3 members · 176 facts
- Heart Valves60 · Dec 2017 to Sep 2021
- Advanced Circulatory Support58 · Dec 2017 to Sep 2021
- Cardiopulmonary58 · Dec 2017 to Sep 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.